News
This is the news section. Posts added here are included in the RSS feed and, for two days after publication, the Google News sitemap. Longer research stays on the blog.
- Houston Rx recalled 64 tirzepatide/niacinamide vials
FDA Enforcement Report event 99990 is Houston Rx LLC's Class II recall of 64 tirzepatide/niacinamide vials. The record names no telehealth brand.
- EMA committee recommends Lilly's Foundayo pill
EMA's committee recommended EU authorization for Lilly's Foundayo pill. That step does not change the U.S. self-pay prices already published here.
- FDA import alert lists two Chinese GLP-1 ingredient makers
Import Alert 66-40 lists two Chinese plants that made semaglutide and tirzepatide ingredients. The catalog records price, not which supplier a provider uses.
- FDA peptide compounding policy is pending White House review
OIRA lists a pending FDA peptide-compounding notice received 14 October 2026. The text is not public, and none of the six named peptides is a product we price.